NYSEArca - Delayed Quote USD

Principal Investment Grade Corporate Active ETF (IG)

20.06 -0.05 (-0.24%)
At close: April 24 at 4:00 PM EDT
Loading Chart for IG
DELL
  • Previous Close 20.11
  • Open 20.10
  • Bid --
  • Ask 24.94 x 1000
  • Day's Range 20.01 - 20.10
  • 52 Week Range 19.05 - 21.10
  • Volume 14,627
  • Avg. Volume 20,025
  • Net Assets 77.47M
  • NAV 20.05
  • PE Ratio (TTM) --
  • Yield 4.62%
  • YTD Daily Total Return -3.21%
  • Beta (5Y Monthly) 1.26
  • Expense Ratio (net) 0.19%

The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets, plus any borrowings for investment purposes, in investment grade corporate bonds and other fixed income securities at the time of purchase. "Investment grade" securities are rated BBB- or higher by S&P Global Ratings ("S&P Global") or Baa3 or higher by Moody's Investors Service, Inc. ("Moody's") or, if unrated, of comparable quality in the opinion of those selecting such investments.

Principal Funds

Fund Family

Corporate Bond

Fund Category

77.47M

Net Assets

2018-04-18

Inception Date

Performance Overview: IG

Trailing returns as of 4/24/2024. Category is Corporate Bond.

YTD Return

IG
3.21%
Category
0.01%
 

1-Year Return

IG
0.47%
Category
4.69%
 

3-Year Return

IG
3.99%
Category
1.75%
 

People Also Watch

Related ETF News

Research Reports: IG

  • CORT: Lowering target price to $18.00

    CORCEPT THERAPEUTICS INC has an Investment Rating of SELL; a target price of $18.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CORT: Lowering target price to $19.00

    CORCEPT THERAPEUTICS INC has an Investment Rating of SELL; a target price of $19.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CORT: What does Argus have to say about CORT?

    CORCEPT THERAPEUTICS INC has an Investment Rating of SELL; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CORT: Lowering target price to $20.00

    CORCEPT THERAPEUTICS INC has an Investment Rating of SELL; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
     

Related Tickers